Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21045-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- ESRP1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated ESRP1 antibody (Cat. #21045-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ESRP1 controls biogenesis and function of a large abundant multiexon circRNA.
ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer.
Silencing ESRP1 expression promotes caspase-independent cell death via nuclear translocation of AIF in colon cancer cells.
Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression.
Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing.
Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop.
circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis.
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer.
Liu D, Dredge BK, Bert AG, Pillman KA, Toubia J, Guo W, Dyakov BJA, Migault MM, Conn VM, Conn SJ, Gregory PA, Gingras AC, Patel D, Wu B, Goodall GJ
Nucleic acids research 2024 Feb 9;52(3):1387-1403
Nucleic acids research 2024 Feb 9;52(3):1387-1403
ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer.
Li C, Yin Y, Tao R, Lin Y, Wang T, Shen Q, Li R, Tao K, Liu W
Cell death discovery 2023 Dec 19;9(1):464
Cell death discovery 2023 Dec 19;9(1):464
Silencing ESRP1 expression promotes caspase-independent cell death via nuclear translocation of AIF in colon cancer cells.
Vadlamudi Y, Kang SC
Cellular signalling 2022 Mar;91:110237
Cellular signalling 2022 Mar;91:110237
Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression.
Chen S, Wu W, Li QH, Xie BM, Shen F, Du YP, Zong ZH, Wang LL, Wei XQ, Zhao Y
Cell death discovery 2021 Jan 22;7(1):22
Cell death discovery 2021 Jan 22;7(1):22
Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing.
Shah K, Gagliano T, Garland L, O'Hanlon T, Bortolotti D, Gentili V, Rizzo R, Giamas G, Dean M
Oncogene 2020 Sep;39(39):6172-6189
Oncogene 2020 Sep;39(39):6172-6189
Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop.
Zhao W, Cui Y, Liu L, Qi X, Liu J, Ma S, Hu X, Zhang Z, Wang Y, Li H, Wang Z, Liu Z, Wu J
Cell death and differentiation 2020 Mar;27(3):919-933
Cell death and differentiation 2020 Mar;27(3):919-933
circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis.
Zhou C, Liu HS, Wang FW, Hu T, Liang ZX, Lan N, He XW, Zheng XB, Wu XJ, Xie D, Wu XR, Lan P
Molecular therapy : the journal of the American Society of Gene Therapy 2020 Mar 4;28(3):914-928
Molecular therapy : the journal of the American Society of Gene Therapy 2020 Mar 4;28(3):914-928
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer.
Adams CR, Htwe HH, Marsh T, Wang AL, Montoya ML, Subbaraj L, Tward AD, Bardeesy N, Perera RM
eLife 2019 May 28;8
eLife 2019 May 28;8
No comments: Submit comment
No validations: Submit validation data